BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 20 hits from ConjuChem Inc.   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152769
PNG
(CHEMBL410972 | GLP-1(7-36)-NH2 | GLP-17-(7-36) der...)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(N)=O
Show InChI InChI=1S/C149H226N40O45/c1-17-76(10)119(146(232)167-80(14)126(212)175-104(60-86-63-159-91-36-25-24-35-89(86)91)136(222)177-100(56-73(4)5)137(223)186-117(74(6)7)144(230)174-93(37-26-28-52-150)128(214)160-65-110(197)168-92(122(154)208)39-30-54-158-149(155)156)188-138(224)102(57-83-31-20-18-21-32-83)178-133(219)98(47-51-115(204)205)173-132(218)94(38-27-29-53-151)170-124(210)78(12)164-123(209)77(11)166-131(217)97(44-48-109(153)196)169-111(198)66-161-130(216)96(46-50-114(202)203)172-134(220)99(55-72(2)3)176-135(221)101(59-85-40-42-88(195)43-41-85)179-141(227)106(68-190)182-143(229)108(70-192)183-145(231)118(75(8)9)187-140(226)105(62-116(206)207)180-142(228)107(69-191)184-148(234)121(82(16)194)189-139(225)103(58-84-33-22-19-23-34-84)181-147(233)120(81(15)193)185-112(199)67-162-129(215)95(45-49-113(200)201)171-125(211)79(13)165-127(213)90(152)61-87-64-157-71-163-87/h18-25,31-36,40-43,63-64,71-82,90,92-108,117-121,159,190-195H,17,26-30,37-39,44-62,65-70,150-152H2,1-16H3,(H2,153,196)(H2,154,208)(H,157,163)(H,160,214)(H,161,216)(H,162,215)(H,164,209)(H,165,213)(H,166,217)(H,167,232)(H,168,197)(H,169,198)(H,170,210)(H,171,211)(H,172,220)(H,173,218)(H,174,230)(H,175,212)(H,176,221)(H,177,222)(H,178,219)(H,179,227)(H,180,228)(H,181,233)(H,182,229)(H,183,231)(H,184,234)(H,185,199)(H,186,223)(H,187,226)(H,188,224)(H,189,225)(H,200,201)(H,202,203)(H,204,205)(H,206,207)(H4,155,156,158)/t76-,77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-,121-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.140n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration against human GLP1 receptor expressed in CHO cell membrane homogenates with 1%DMSO


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152769
PNG
(CHEMBL410972 | GLP-1(7-36)-NH2 | GLP-17-(7-36) der...)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(N)=O
Show InChI InChI=1S/C149H226N40O45/c1-17-76(10)119(146(232)167-80(14)126(212)175-104(60-86-63-159-91-36-25-24-35-89(86)91)136(222)177-100(56-73(4)5)137(223)186-117(74(6)7)144(230)174-93(37-26-28-52-150)128(214)160-65-110(197)168-92(122(154)208)39-30-54-158-149(155)156)188-138(224)102(57-83-31-20-18-21-32-83)178-133(219)98(47-51-115(204)205)173-132(218)94(38-27-29-53-151)170-124(210)78(12)164-123(209)77(11)166-131(217)97(44-48-109(153)196)169-111(198)66-161-130(216)96(46-50-114(202)203)172-134(220)99(55-72(2)3)176-135(221)101(59-85-40-42-88(195)43-41-85)179-141(227)106(68-190)182-143(229)108(70-192)183-145(231)118(75(8)9)187-140(226)105(62-116(206)207)180-142(228)107(69-191)184-148(234)121(82(16)194)189-139(225)103(58-84-33-22-19-23-34-84)181-147(233)120(81(15)193)185-112(199)67-162-129(215)95(45-49-113(200)201)171-125(211)79(13)165-127(213)90(152)61-87-64-157-71-163-87/h18-25,31-36,40-43,63-64,71-82,90,92-108,117-121,159,190-195H,17,26-30,37-39,44-62,65-70,150-152H2,1-16H3,(H2,153,196)(H2,154,208)(H,157,163)(H,160,214)(H,161,216)(H,162,215)(H,164,209)(H,165,213)(H,166,217)(H,167,232)(H,168,197)(H,169,198)(H,170,210)(H,171,211)(H,172,220)(H,173,218)(H,174,230)(H,175,212)(H,176,221)(H,177,222)(H,178,219)(H,179,227)(H,180,228)(H,181,233)(H,182,229)(H,183,231)(H,184,234)(H,185,199)(H,186,223)(H,187,226)(H,188,224)(H,189,225)(H,200,201)(H,202,203)(H,204,205)(H,206,207)(H4,155,156,158)/t76-,77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-,121-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 14n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration required against human GLP1 receptor expressed in CHO cell membrane homogenates


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50024276
PNG
(CHEMBL2371792)
Show InChI InChI=1S/C168H254N44O52/c1-17-89(10)137(165(260)188-93(14)144(239)197-118(72-99-75-180-104-38-25-24-37-102(99)104)155(250)199-114(68-86(4)5)156(251)208-135(87(6)7)163(258)196-106(40-26-29-58-169)146(241)181-77-125(221)189-107(42-32-61-179-168(174)175)150(245)191-105(140(173)235)39-28-31-60-177-128(224)83-264-66-65-263-64-62-178-124(220)57-63-212-129(225)52-53-130(212)226)210-157(252)116(69-96-33-20-18-21-34-96)200-152(247)112(50-56-133(231)232)195-151(246)108(41-27-30-59-170)192-142(237)91(12)185-141(236)90(11)187-149(244)111(47-51-123(172)219)190-126(222)78-182-148(243)110(49-55-132(229)230)194-153(248)113(67-85(2)3)198-154(249)115(71-98-43-45-101(218)46-44-98)201-160(255)120(80-213)204-162(257)122(82-215)205-164(259)136(88(8)9)209-159(254)119(74-134(233)234)202-161(256)121(81-214)206-167(262)139(95(16)217)211-158(253)117(70-97-35-22-19-23-36-97)203-166(261)138(94(15)216)207-127(223)79-183-147(242)109(48-54-131(227)228)193-143(238)92(13)186-145(240)103(171)73-100-76-176-84-184-100/h18-25,33-38,43-46,52-53,75-76,84-95,103,105-122,135-139,180,213-218H,17,26-32,39-42,47-51,54-74,77-83,169-171H2,1-16H3,(H2,172,219)(H2,173,235)(H,176,184)(H,177,224)(H,178,220)(H,181,241)(H,182,243)(H,183,242)(H,185,236)(H,186,240)(H,187,244)(H,188,260)(H,189,221)(H,190,222)(H,191,245)(H,192,237)(H,193,238)(H,194,248)(H,195,246)(H,196,258)(H,197,239)(H,198,249)(H,199,250)(H,200,247)(H,201,255)(H,202,256)(H,203,261)(H,204,257)(H,205,259)(H,206,262)(H,207,223)(H,208,251)(H,209,254)(H,210,252)(H,211,253)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H4,174,175,179)/t89-,90-,91-,92-,93-,94+,95+,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,135-,136-,137-,138-,139-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 87n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration required against human GLP1 receptor expressed in CHO cell membrane homogenates


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50024277
PNG
(CHEMBL2371793)
Show InChI InChI=1S/C168H254N44O52/c1-17-89(10)137(165(260)188-93(14)144(239)197-118(72-99-75-180-104-38-25-24-37-102(99)104)155(250)199-114(68-86(4)5)156(251)208-135(87(6)7)163(258)196-106(40-26-29-58-169)146(241)181-77-125(221)189-107(42-32-61-179-168(174)175)150(245)191-105(140(173)235)39-28-31-60-177-128(224)83-264-66-65-263-64-62-178-124(220)57-63-212-129(225)52-53-130(212)226)210-157(252)116(69-96-33-20-18-21-34-96)200-152(247)112(50-56-133(231)232)195-151(246)108(41-27-30-59-170)192-142(237)91(12)185-141(236)90(11)187-149(244)111(47-51-123(172)219)190-126(222)78-182-148(243)110(49-55-132(229)230)194-153(248)113(67-85(2)3)198-154(249)115(71-98-43-45-101(218)46-44-98)201-160(255)120(80-213)204-162(257)122(82-215)205-164(259)136(88(8)9)209-159(254)119(74-134(233)234)202-161(256)121(81-214)206-167(262)139(95(16)217)211-158(253)117(70-97-35-22-19-23-36-97)203-166(261)138(94(15)216)207-127(223)79-183-147(242)109(48-54-131(227)228)193-143(238)92(13)186-145(240)103(171)73-100-76-176-84-184-100/h18-25,33-38,43-46,52-53,75-76,84-95,103,105-122,135-139,180,213-218H,17,26-32,39-42,47-51,54-74,77-83,169-171H2,1-16H3,(H2,172,219)(H2,173,235)(H,176,184)(H,177,224)(H,178,220)(H,181,241)(H,182,243)(H,183,242)(H,185,236)(H,186,240)(H,187,244)(H,188,260)(H,189,221)(H,190,222)(H,191,245)(H,192,237)(H,193,238)(H,194,248)(H,195,246)(H,196,258)(H,197,239)(H,198,249)(H,199,250)(H,200,247)(H,201,255)(H,202,256)(H,203,261)(H,204,257)(H,205,259)(H,206,262)(H,207,223)(H,208,251)(H,209,254)(H,210,252)(H,211,253)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H4,174,175,179)/t89-,90-,91-,92+,93-,94+,95+,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,135-,136-,137-,138-,139-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 108n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration required against human GLP1 receptor expressed in CHO cell membrane homogenates


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152773
PNG
(CHEMBL412288 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C161H240N42O51/c1-17-84(10)131(158(250)180-88(14)138(230)188-112(67-94-70-172-99-35-25-24-34-97(94)99)148(240)190-108(63-81(4)5)149(241)199-129(82(6)7)156(248)187-101(140(232)173-72-119(212)181-100(134(165)226)37-28-56-171-161(166)167)38-29-55-169-122(215)78-254-61-60-253-59-57-170-118(211)53-58-203-123(216)48-49-124(203)217)201-150(242)110(64-91-30-20-18-21-31-91)191-145(237)106(46-52-127(222)223)186-144(236)102(36-26-27-54-162)183-136(228)86(12)177-135(227)85(11)179-143(235)105(43-47-117(164)210)182-120(213)73-174-142(234)104(45-51-126(220)221)185-146(238)107(62-80(2)3)189-147(239)109(66-93-39-41-96(209)42-40-93)192-153(245)114(75-204)195-155(247)116(77-206)196-157(249)130(83(8)9)200-152(244)113(69-128(224)225)193-154(246)115(76-205)197-160(252)133(90(16)208)202-151(243)111(65-92-32-22-19-23-33-92)194-159(251)132(89(15)207)198-121(214)74-175-141(233)103(44-50-125(218)219)184-137(229)87(13)178-139(231)98(163)68-95-71-168-79-176-95/h18-25,30-35,39-42,48-49,70-71,79-90,98,100-116,129-133,172,204-209H,17,26-29,36-38,43-47,50-69,72-78,162-163H2,1-16H3,(H2,164,210)(H2,165,226)(H,168,176)(H,169,215)(H,170,211)(H,173,232)(H,174,234)(H,175,233)(H,177,227)(H,178,231)(H,179,235)(H,180,250)(H,181,212)(H,182,213)(H,183,228)(H,184,229)(H,185,238)(H,186,236)(H,187,248)(H,188,230)(H,189,239)(H,190,240)(H,191,237)(H,192,245)(H,193,246)(H,194,251)(H,195,247)(H,196,249)(H,197,252)(H,198,214)(H,199,241)(H,200,244)(H,201,242)(H,202,243)(H,218,219)(H,220,221)(H,222,223)(H,224,225)(H4,166,167,171)/t84-,85-,86-,87-,88-,89+,90+,98-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,129-,130-,131-,132-,133-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 296n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration required against human GLP1 receptor expressed in CHO cell membrane homogenates


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152772
PNG
(CHEMBL409873 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C163H246N42O50/c1-17-87(10)133(160(251)182-91(14)140(231)190-115(70-97-73-174-102-38-25-24-37-100(97)102)150(241)192-111(66-84(4)5)151(242)201-131(85(6)7)158(249)189-104(39-26-29-56-164)142(233)175-75-121(213)183-103(136(167)227)42-32-59-173-163(168)169)203-152(243)113(67-94-33-20-18-21-34-94)193-147(238)109(49-54-129(223)224)188-146(237)106(40-27-30-57-165)185-138(229)89(12)179-137(228)88(11)181-145(236)105(41-28-31-58-171-124(216)81-255-64-63-254-62-60-172-120(212)55-61-205-125(217)50-51-126(205)218)184-122(214)76-176-144(235)108(48-53-128(221)222)187-148(239)110(65-83(2)3)191-149(240)112(69-96-43-45-99(211)46-44-96)194-155(246)117(78-206)197-157(248)119(80-208)198-159(250)132(86(8)9)202-154(245)116(72-130(225)226)195-156(247)118(79-207)199-162(253)135(93(16)210)204-153(244)114(68-95-35-22-19-23-36-95)196-161(252)134(92(15)209)200-123(215)77-177-143(234)107(47-52-127(219)220)186-139(230)90(13)180-141(232)101(166)71-98-74-170-82-178-98/h18-25,33-38,43-46,50-51,73-74,82-93,101,103-119,131-135,174,206-211H,17,26-32,39-42,47-49,52-72,75-81,164-166H2,1-16H3,(H2,167,227)(H,170,178)(H,171,216)(H,172,212)(H,175,233)(H,176,235)(H,177,234)(H,179,228)(H,180,232)(H,181,236)(H,182,251)(H,183,213)(H,184,214)(H,185,229)(H,186,230)(H,187,239)(H,188,237)(H,189,249)(H,190,231)(H,191,240)(H,192,241)(H,193,238)(H,194,246)(H,195,247)(H,196,252)(H,197,248)(H,198,250)(H,199,253)(H,200,215)(H,201,242)(H,202,245)(H,203,243)(H,204,244)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H4,168,169,173)/t87-,88-,89-,90-,91-,92+,93+,101-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,131-,132-,133-,134-,135-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 454n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration required against human GLP1 receptor expressed in CHO cell membrane homogenates


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152770
PNG
(CHEMBL439104 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C165H249N43O50/c1-17-88(10)135(162(254)185-92(14)142(234)194-117(72-98-75-177-103-38-25-24-37-101(98)103)153(245)196-113(68-85(4)5)154(246)204-133(86(6)7)160(252)193-105(39-26-29-58-166)144(236)178-77-123(216)186-104(138(170)230)42-32-61-176-165(171)172)206-155(247)115(69-95-33-20-18-21-34-95)198-150(242)111(50-56-131(226)227)192-148(240)106(40-27-30-59-167)188-140(232)90(12)182-139(231)89(11)184-147(239)110(47-51-121(169)214)187-124(217)78-179-146(238)109(49-55-130(224)225)191-151(243)112(67-84(2)3)195-152(244)114(71-97-43-45-100(213)46-44-97)197-149(241)107(41-28-31-60-174-126(219)82-258-66-65-257-64-62-175-122(215)57-63-208-127(220)52-53-128(208)221)190-158(250)119(80-209)201-161(253)134(87(8)9)205-157(249)118(74-132(228)229)199-159(251)120(81-210)202-164(256)137(94(16)212)207-156(248)116(70-96-35-22-19-23-36-96)200-163(255)136(93(15)211)203-125(218)79-180-145(237)108(48-54-129(222)223)189-141(233)91(13)183-143(235)102(168)73-99-76-173-83-181-99/h18-25,33-38,43-46,52-53,75-76,83-94,102,104-120,133-137,177,209-213H,17,26-32,39-42,47-51,54-74,77-82,166-168H2,1-16H3,(H2,169,214)(H2,170,230)(H,173,181)(H,174,219)(H,175,215)(H,178,236)(H,179,238)(H,180,237)(H,182,231)(H,183,235)(H,184,239)(H,185,254)(H,186,216)(H,187,217)(H,188,232)(H,189,233)(H,190,250)(H,191,243)(H,192,240)(H,193,252)(H,194,234)(H,195,244)(H,196,245)(H,197,241)(H,198,242)(H,199,251)(H,200,255)(H,201,253)(H,202,256)(H,203,218)(H,204,246)(H,205,249)(H,206,247)(H,207,248)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H4,171,172,176)/t88-,89-,90-,91-,92-,93+,94+,102-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,133-,134-,135-,136-,137-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 713n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration required against human GLP1 receptor expressed in CHO cell membrane homogenates


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152767
PNG
(CHEMBL410973 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C162H242N42O51/c1-17-85(10)132(159(251)181-89(14)139(231)189-113(68-95-71-173-100-36-25-24-35-98(95)100)149(241)191-109(64-82(4)5)150(242)200-130(83(6)7)157(249)188-102(37-26-28-55-163)141(233)174-73-120(213)182-101(135(166)227)39-30-57-172-162(167)168)202-151(243)111(65-92-31-20-18-21-32-92)192-146(238)107(47-53-128(223)224)187-145(237)103(38-27-29-56-170-123(216)79-255-62-61-254-60-58-171-119(212)54-59-204-124(217)49-50-125(204)218)184-137(229)87(12)178-136(228)86(11)180-144(236)106(44-48-118(165)211)183-121(214)74-175-143(235)105(46-52-127(221)222)186-147(239)108(63-81(2)3)190-148(240)110(67-94-40-42-97(210)43-41-94)193-154(246)115(76-205)196-156(248)117(78-207)197-158(250)131(84(8)9)201-153(245)114(70-129(225)226)194-155(247)116(77-206)198-161(253)134(91(16)209)203-152(244)112(66-93-33-22-19-23-34-93)195-160(252)133(90(15)208)199-122(215)75-176-142(234)104(45-51-126(219)220)185-138(230)88(13)179-140(232)99(164)69-96-72-169-80-177-96/h18-25,31-36,40-43,49-50,71-72,80-91,99,101-117,130-134,173,205-210H,17,26-30,37-39,44-48,51-70,73-79,163-164H2,1-16H3,(H2,165,211)(H2,166,227)(H,169,177)(H,170,216)(H,171,212)(H,174,233)(H,175,235)(H,176,234)(H,178,228)(H,179,232)(H,180,236)(H,181,251)(H,182,213)(H,183,214)(H,184,229)(H,185,230)(H,186,239)(H,187,237)(H,188,249)(H,189,231)(H,190,240)(H,191,241)(H,192,238)(H,193,246)(H,194,247)(H,195,252)(H,196,248)(H,197,250)(H,198,253)(H,199,215)(H,200,242)(H,201,245)(H,202,243)(H,203,244)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H4,167,168,172)/t85-,86-,87-,88-,89-,90+,91+,99-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,130-,131-,132-,133-,134-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 804n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration required against human GLP1 receptor expressed in CHO cell membrane homogenates


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152768
PNG
(CHEMBL265428 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C162H242N42O51/c1-17-85(10)132(159(251)180-89(14)139(231)189-112(68-95-71-172-99-36-25-24-35-98(95)99)149(241)191-108(64-82(4)5)150(242)200-130(83(6)7)157(249)188-101(37-26-28-55-163)140(232)173-73-120(213)181-100(135(166)227)39-30-57-171-162(167)168)202-151(243)110(65-92-31-20-18-21-32-92)192-145(237)106(47-53-128(223)224)187-144(236)102(38-27-29-56-164)184-137(229)87(12)177-136(228)86(11)178-143(235)105(44-48-118(165)211)182-121(214)74-174-142(234)104(46-52-127(221)222)186-147(239)107(63-81(2)3)190-148(240)109(67-94-40-42-97(210)43-41-94)193-154(246)115(76-205)196-156(248)117(78-207)197-158(250)131(84(8)9)201-153(245)114(70-129(225)226)194-155(247)116(77-206)198-161(253)134(91(16)209)203-152(244)111(66-93-33-22-19-23-34-93)195-160(252)133(90(15)208)199-122(215)75-175-141(233)103(45-51-126(219)220)185-138(230)88(13)179-146(238)113(69-96-72-169-80-176-96)183-123(216)79-255-62-61-254-60-58-170-119(212)54-59-204-124(217)49-50-125(204)218/h18-25,31-36,40-43,49-50,71-72,80-91,100-117,130-134,172,205-210H,17,26-30,37-39,44-48,51-70,73-79,163-164H2,1-16H3,(H2,165,211)(H2,166,227)(H,169,176)(H,170,212)(H,173,232)(H,174,234)(H,175,233)(H,177,228)(H,178,235)(H,179,238)(H,180,251)(H,181,213)(H,182,214)(H,183,216)(H,184,229)(H,185,230)(H,186,239)(H,187,236)(H,188,249)(H,189,231)(H,190,240)(H,191,241)(H,192,237)(H,193,246)(H,194,247)(H,195,252)(H,196,248)(H,197,250)(H,198,253)(H,199,215)(H,200,242)(H,201,245)(H,202,243)(H,203,244)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H4,167,168,171)/t85-,86-,87-,88-,89-,90+,91+,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,130-,131-,132-,133-,134-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 5.35E+3n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration required against human GLP1 receptor expressed in CHO cell membrane homogenates


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152775
PNG
(CHEMBL409371 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C159H245N43O51/c1-17-83(10)129(156(249)179-87(14)136(229)188-110(66-92-69-171-97-33-22-21-32-95(92)97)147(240)190-107(63-80(4)5)148(241)198-127(81(6)7)154(247)187-99(34-23-26-53-160)138(231)172-71-117(211)180-98(132(164)225)37-29-56-170-159(165)166)200-144(237)101(36-25-28-55-168-120(214)77-253-61-60-252-59-57-169-116(210)52-58-202-121(215)47-48-122(202)216)184-143(236)105(45-51-125(221)222)186-142(235)100(35-24-27-54-161)182-134(227)85(12)176-133(226)84(11)178-141(234)104(42-46-115(163)209)181-118(212)72-173-140(233)103(44-50-124(219)220)185-145(238)106(62-79(2)3)189-146(239)108(65-91-38-40-94(208)41-39-91)191-151(244)112(74-203)194-153(246)114(76-205)195-155(248)128(82(8)9)199-150(243)111(68-126(223)224)192-152(245)113(75-204)196-158(251)131(89(16)207)201-149(242)109(64-90-30-19-18-20-31-90)193-157(250)130(88(15)206)197-119(213)73-174-139(232)102(43-49-123(217)218)183-135(228)86(13)177-137(230)96(162)67-93-70-167-78-175-93/h18-22,30-33,38-41,47-48,69-70,78-89,96,98-114,127-131,171,203-208H,17,23-29,34-37,42-46,49-68,71-77,160-162H2,1-16H3,(H2,163,209)(H2,164,225)(H,167,175)(H,168,214)(H,169,210)(H,172,231)(H,173,233)(H,174,232)(H,176,226)(H,177,230)(H,178,234)(H,179,249)(H,180,211)(H,181,212)(H,182,227)(H,183,228)(H,184,236)(H,185,238)(H,186,235)(H,187,247)(H,188,229)(H,189,239)(H,190,240)(H,191,244)(H,192,245)(H,193,250)(H,194,246)(H,195,248)(H,196,251)(H,197,213)(H,198,241)(H,199,243)(H,200,237)(H,201,242)(H,217,218)(H,219,220)(H,221,222)(H,223,224)(H4,165,166,170)/t83-,84-,85-,86-,87-,88+,89+,96-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,127-,128-,129-,130-,131-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>1.00E+4n/an/an/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Inhibitory concentration required against human GLP1 receptor expressed in CHO cell membrane homogenates


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50024277
PNG
(CHEMBL2371793)
Show InChI InChI=1S/C168H254N44O52/c1-17-89(10)137(165(260)188-93(14)144(239)197-118(72-99-75-180-104-38-25-24-37-102(99)104)155(250)199-114(68-86(4)5)156(251)208-135(87(6)7)163(258)196-106(40-26-29-58-169)146(241)181-77-125(221)189-107(42-32-61-179-168(174)175)150(245)191-105(140(173)235)39-28-31-60-177-128(224)83-264-66-65-263-64-62-178-124(220)57-63-212-129(225)52-53-130(212)226)210-157(252)116(69-96-33-20-18-21-34-96)200-152(247)112(50-56-133(231)232)195-151(246)108(41-27-30-59-170)192-142(237)91(12)185-141(236)90(11)187-149(244)111(47-51-123(172)219)190-126(222)78-182-148(243)110(49-55-132(229)230)194-153(248)113(67-85(2)3)198-154(249)115(71-98-43-45-101(218)46-44-98)201-160(255)120(80-213)204-162(257)122(82-215)205-164(259)136(88(8)9)209-159(254)119(74-134(233)234)202-161(256)121(81-214)206-167(262)139(95(16)217)211-158(253)117(70-97-35-22-19-23-36-97)203-166(261)138(94(15)216)207-127(223)79-183-147(242)109(48-54-131(227)228)193-143(238)92(13)186-145(240)103(171)73-100-76-176-84-184-100/h18-25,33-38,43-46,52-53,75-76,84-95,103,105-122,135-139,180,213-218H,17,26-32,39-42,47-51,54-74,77-83,169-171H2,1-16H3,(H2,172,219)(H2,173,235)(H,176,184)(H,177,224)(H,178,220)(H,181,241)(H,182,243)(H,183,242)(H,185,236)(H,186,240)(H,187,244)(H,188,260)(H,189,221)(H,190,222)(H,191,245)(H,192,237)(H,193,238)(H,194,248)(H,195,246)(H,196,258)(H,197,239)(H,198,249)(H,199,250)(H,200,247)(H,201,255)(H,202,256)(H,203,261)(H,204,257)(H,205,259)(H,206,262)(H,207,223)(H,208,251)(H,209,254)(H,210,252)(H,211,253)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H4,174,175,179)/t89-,90-,91-,92+,93-,94+,95+,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,135-,136-,137-,138-,139-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 15n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152768
PNG
(CHEMBL265428 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C162H242N42O51/c1-17-85(10)132(159(251)180-89(14)139(231)189-112(68-95-71-172-99-36-25-24-35-98(95)99)149(241)191-108(64-82(4)5)150(242)200-130(83(6)7)157(249)188-101(37-26-28-55-163)140(232)173-73-120(213)181-100(135(166)227)39-30-57-171-162(167)168)202-151(243)110(65-92-31-20-18-21-32-92)192-145(237)106(47-53-128(223)224)187-144(236)102(38-27-29-56-164)184-137(229)87(12)177-136(228)86(11)178-143(235)105(44-48-118(165)211)182-121(214)74-174-142(234)104(46-52-127(221)222)186-147(239)107(63-81(2)3)190-148(240)109(67-94-40-42-97(210)43-41-94)193-154(246)115(76-205)196-156(248)117(78-207)197-158(250)131(84(8)9)201-153(245)114(70-129(225)226)194-155(247)116(77-206)198-161(253)134(91(16)209)203-152(244)111(66-93-33-22-19-23-34-93)195-160(252)133(90(15)208)199-122(215)75-175-141(233)103(45-51-126(219)220)185-138(230)88(13)179-146(238)113(69-96-72-169-80-176-96)183-123(216)79-255-62-61-254-60-58-170-119(212)54-59-204-124(217)49-50-125(204)218/h18-25,31-36,40-43,49-50,71-72,80-91,100-117,130-134,172,205-210H,17,26-30,37-39,44-48,51-70,73-79,163-164H2,1-16H3,(H2,165,211)(H2,166,227)(H,169,176)(H,170,212)(H,173,232)(H,174,234)(H,175,233)(H,177,228)(H,178,235)(H,179,238)(H,180,251)(H,181,213)(H,182,214)(H,183,216)(H,184,229)(H,185,230)(H,186,239)(H,187,236)(H,188,249)(H,189,231)(H,190,240)(H,191,241)(H,192,237)(H,193,246)(H,194,247)(H,195,252)(H,196,248)(H,197,250)(H,198,253)(H,199,215)(H,200,242)(H,201,245)(H,202,243)(H,203,244)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H4,167,168,171)/t85-,86-,87-,88-,89-,90+,91+,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,130-,131-,132-,133-,134-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a>1.00E+3n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152770
PNG
(CHEMBL439104 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C165H249N43O50/c1-17-88(10)135(162(254)185-92(14)142(234)194-117(72-98-75-177-103-38-25-24-37-101(98)103)153(245)196-113(68-85(4)5)154(246)204-133(86(6)7)160(252)193-105(39-26-29-58-166)144(236)178-77-123(216)186-104(138(170)230)42-32-61-176-165(171)172)206-155(247)115(69-95-33-20-18-21-34-95)198-150(242)111(50-56-131(226)227)192-148(240)106(40-27-30-59-167)188-140(232)90(12)182-139(231)89(11)184-147(239)110(47-51-121(169)214)187-124(217)78-179-146(238)109(49-55-130(224)225)191-151(243)112(67-84(2)3)195-152(244)114(71-97-43-45-100(213)46-44-97)197-149(241)107(41-28-31-60-174-126(219)82-258-66-65-257-64-62-175-122(215)57-63-208-127(220)52-53-128(208)221)190-158(250)119(80-209)201-161(253)134(87(8)9)205-157(249)118(74-132(228)229)199-159(251)120(81-210)202-164(256)137(94(16)212)207-156(248)116(70-96-35-22-19-23-36-96)200-163(255)136(93(15)211)203-125(218)79-180-145(237)108(48-54-129(222)223)189-141(233)91(13)183-143(235)102(168)73-99-76-173-83-181-99/h18-25,33-38,43-46,52-53,75-76,83-94,102,104-120,133-137,177,209-213H,17,26-32,39-42,47-51,54-74,77-82,166-168H2,1-16H3,(H2,169,214)(H2,170,230)(H,173,181)(H,174,219)(H,175,215)(H,178,236)(H,179,238)(H,180,237)(H,182,231)(H,183,235)(H,184,239)(H,185,254)(H,186,216)(H,187,217)(H,188,232)(H,189,233)(H,190,250)(H,191,243)(H,192,240)(H,193,252)(H,194,234)(H,195,244)(H,196,245)(H,197,241)(H,198,242)(H,199,251)(H,200,255)(H,201,253)(H,202,256)(H,203,218)(H,204,246)(H,205,249)(H,206,247)(H,207,248)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H4,171,172,176)/t88-,89-,90-,91-,92-,93+,94+,102-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,133-,134-,135-,136-,137-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 28n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152769
PNG
(CHEMBL410972 | GLP-1(7-36)-NH2 | GLP-17-(7-36) der...)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(N)=O
Show InChI InChI=1S/C149H226N40O45/c1-17-76(10)119(146(232)167-80(14)126(212)175-104(60-86-63-159-91-36-25-24-35-89(86)91)136(222)177-100(56-73(4)5)137(223)186-117(74(6)7)144(230)174-93(37-26-28-52-150)128(214)160-65-110(197)168-92(122(154)208)39-30-54-158-149(155)156)188-138(224)102(57-83-31-20-18-21-32-83)178-133(219)98(47-51-115(204)205)173-132(218)94(38-27-29-53-151)170-124(210)78(12)164-123(209)77(11)166-131(217)97(44-48-109(153)196)169-111(198)66-161-130(216)96(46-50-114(202)203)172-134(220)99(55-72(2)3)176-135(221)101(59-85-40-42-88(195)43-41-85)179-141(227)106(68-190)182-143(229)108(70-192)183-145(231)118(75(8)9)187-140(226)105(62-116(206)207)180-142(228)107(69-191)184-148(234)121(82(16)194)189-139(225)103(58-84-33-22-19-23-34-84)181-147(233)120(81(15)193)185-112(199)67-162-129(215)95(45-49-113(200)201)171-125(211)79(13)165-127(213)90(152)61-87-64-157-71-163-87/h18-25,31-36,40-43,63-64,71-82,90,92-108,117-121,159,190-195H,17,26-30,37-39,44-62,65-70,150-152H2,1-16H3,(H2,153,196)(H2,154,208)(H,157,163)(H,160,214)(H,161,216)(H,162,215)(H,164,209)(H,165,213)(H,166,217)(H,167,232)(H,168,197)(H,169,198)(H,170,210)(H,171,211)(H,172,220)(H,173,218)(H,174,230)(H,175,212)(H,176,221)(H,177,222)(H,178,219)(H,179,227)(H,180,228)(H,181,233)(H,182,229)(H,183,231)(H,184,234)(H,185,199)(H,186,223)(H,187,226)(H,188,224)(H,189,225)(H,200,201)(H,202,203)(H,204,205)(H,206,207)(H4,155,156,158)/t76-,77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-,121-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 15n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152769
PNG
(CHEMBL410972 | GLP-1(7-36)-NH2 | GLP-17-(7-36) der...)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(N)=O
Show InChI InChI=1S/C149H226N40O45/c1-17-76(10)119(146(232)167-80(14)126(212)175-104(60-86-63-159-91-36-25-24-35-89(86)91)136(222)177-100(56-73(4)5)137(223)186-117(74(6)7)144(230)174-93(37-26-28-52-150)128(214)160-65-110(197)168-92(122(154)208)39-30-54-158-149(155)156)188-138(224)102(57-83-31-20-18-21-32-83)178-133(219)98(47-51-115(204)205)173-132(218)94(38-27-29-53-151)170-124(210)78(12)164-123(209)77(11)166-131(217)97(44-48-109(153)196)169-111(198)66-161-130(216)96(46-50-114(202)203)172-134(220)99(55-72(2)3)176-135(221)101(59-85-40-42-88(195)43-41-85)179-141(227)106(68-190)182-143(229)108(70-192)183-145(231)118(75(8)9)187-140(226)105(62-116(206)207)180-142(228)107(69-191)184-148(234)121(82(16)194)189-139(225)103(58-84-33-22-19-23-34-84)181-147(233)120(81(15)193)185-112(199)67-162-129(215)95(45-49-113(200)201)171-125(211)79(13)165-127(213)90(152)61-87-64-157-71-163-87/h18-25,31-36,40-43,63-64,71-82,90,92-108,117-121,159,190-195H,17,26-30,37-39,44-62,65-70,150-152H2,1-16H3,(H2,153,196)(H2,154,208)(H,157,163)(H,160,214)(H,161,216)(H,162,215)(H,164,209)(H,165,213)(H,166,217)(H,167,232)(H,168,197)(H,169,198)(H,170,210)(H,171,211)(H,172,220)(H,173,218)(H,174,230)(H,175,212)(H,176,221)(H,177,222)(H,178,219)(H,179,227)(H,180,228)(H,181,233)(H,182,229)(H,183,231)(H,184,234)(H,185,199)(H,186,223)(H,187,226)(H,188,224)(H,189,225)(H,200,201)(H,202,203)(H,204,205)(H,206,207)(H4,155,156,158)/t76-,77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-,121-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 0.400n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells with 1%DMSO


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50024276
PNG
(CHEMBL2371792)
Show InChI InChI=1S/C168H254N44O52/c1-17-89(10)137(165(260)188-93(14)144(239)197-118(72-99-75-180-104-38-25-24-37-102(99)104)155(250)199-114(68-86(4)5)156(251)208-135(87(6)7)163(258)196-106(40-26-29-58-169)146(241)181-77-125(221)189-107(42-32-61-179-168(174)175)150(245)191-105(140(173)235)39-28-31-60-177-128(224)83-264-66-65-263-64-62-178-124(220)57-63-212-129(225)52-53-130(212)226)210-157(252)116(69-96-33-20-18-21-34-96)200-152(247)112(50-56-133(231)232)195-151(246)108(41-27-30-59-170)192-142(237)91(12)185-141(236)90(11)187-149(244)111(47-51-123(172)219)190-126(222)78-182-148(243)110(49-55-132(229)230)194-153(248)113(67-85(2)3)198-154(249)115(71-98-43-45-101(218)46-44-98)201-160(255)120(80-213)204-162(257)122(82-215)205-164(259)136(88(8)9)209-159(254)119(74-134(233)234)202-161(256)121(81-214)206-167(262)139(95(16)217)211-158(253)117(70-97-35-22-19-23-36-97)203-166(261)138(94(15)216)207-127(223)79-183-147(242)109(48-54-131(227)228)193-143(238)92(13)186-145(240)103(171)73-100-76-176-84-184-100/h18-25,33-38,43-46,52-53,75-76,84-95,103,105-122,135-139,180,213-218H,17,26-32,39-42,47-51,54-74,77-83,169-171H2,1-16H3,(H2,172,219)(H2,173,235)(H,176,184)(H,177,224)(H,178,220)(H,181,241)(H,182,243)(H,183,242)(H,185,236)(H,186,240)(H,187,244)(H,188,260)(H,189,221)(H,190,222)(H,191,245)(H,192,237)(H,193,238)(H,194,248)(H,195,246)(H,196,258)(H,197,239)(H,198,249)(H,199,250)(H,200,247)(H,201,255)(H,202,256)(H,203,261)(H,204,257)(H,205,259)(H,206,262)(H,207,223)(H,208,251)(H,209,254)(H,210,252)(H,211,253)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H4,174,175,179)/t89-,90-,91-,92-,93-,94+,95+,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,135-,136-,137-,138-,139-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 24n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152775
PNG
(CHEMBL409371 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C159H245N43O51/c1-17-83(10)129(156(249)179-87(14)136(229)188-110(66-92-69-171-97-33-22-21-32-95(92)97)147(240)190-107(63-80(4)5)148(241)198-127(81(6)7)154(247)187-99(34-23-26-53-160)138(231)172-71-117(211)180-98(132(164)225)37-29-56-170-159(165)166)200-144(237)101(36-25-28-55-168-120(214)77-253-61-60-252-59-57-169-116(210)52-58-202-121(215)47-48-122(202)216)184-143(236)105(45-51-125(221)222)186-142(235)100(35-24-27-54-161)182-134(227)85(12)176-133(226)84(11)178-141(234)104(42-46-115(163)209)181-118(212)72-173-140(233)103(44-50-124(219)220)185-145(238)106(62-79(2)3)189-146(239)108(65-91-38-40-94(208)41-39-91)191-151(244)112(74-203)194-153(246)114(76-205)195-155(248)128(82(8)9)199-150(243)111(68-126(223)224)192-152(245)113(75-204)196-158(251)131(89(16)207)201-149(242)109(64-90-30-19-18-20-31-90)193-157(250)130(88(15)206)197-119(213)73-174-139(232)102(43-49-123(217)218)183-135(228)86(13)177-137(230)96(162)67-93-70-167-78-175-93/h18-22,30-33,38-41,47-48,69-70,78-89,96,98-114,127-131,171,203-208H,17,23-29,34-37,42-46,49-68,71-77,160-162H2,1-16H3,(H2,163,209)(H2,164,225)(H,167,175)(H,168,214)(H,169,210)(H,172,231)(H,173,233)(H,174,232)(H,176,226)(H,177,230)(H,178,234)(H,179,249)(H,180,211)(H,181,212)(H,182,227)(H,183,228)(H,184,236)(H,185,238)(H,186,235)(H,187,247)(H,188,229)(H,189,239)(H,190,240)(H,191,244)(H,192,245)(H,193,250)(H,194,246)(H,195,248)(H,196,251)(H,197,213)(H,198,241)(H,199,243)(H,200,237)(H,201,242)(H,217,218)(H,219,220)(H,221,222)(H,223,224)(H4,165,166,170)/t83-,84-,85-,86-,87-,88+,89+,96-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,127-,128-,129-,130-,131-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a>1.00E+3n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152772
PNG
(CHEMBL409873 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C163H246N42O50/c1-17-87(10)133(160(251)182-91(14)140(231)190-115(70-97-73-174-102-38-25-24-37-100(97)102)150(241)192-111(66-84(4)5)151(242)201-131(85(6)7)158(249)189-104(39-26-29-56-164)142(233)175-75-121(213)183-103(136(167)227)42-32-59-173-163(168)169)203-152(243)113(67-94-33-20-18-21-34-94)193-147(238)109(49-54-129(223)224)188-146(237)106(40-27-30-57-165)185-138(229)89(12)179-137(228)88(11)181-145(236)105(41-28-31-58-171-124(216)81-255-64-63-254-62-60-172-120(212)55-61-205-125(217)50-51-126(205)218)184-122(214)76-176-144(235)108(48-53-128(221)222)187-148(239)110(65-83(2)3)191-149(240)112(69-96-43-45-99(211)46-44-96)194-155(246)117(78-206)197-157(248)119(80-208)198-159(250)132(86(8)9)202-154(245)116(72-130(225)226)195-156(247)118(79-207)199-162(253)135(93(16)210)204-153(244)114(68-95-35-22-19-23-36-95)196-161(252)134(92(15)209)200-123(215)77-177-143(234)107(47-52-127(219)220)186-139(230)90(13)180-141(232)101(166)71-98-74-170-82-178-98/h18-25,33-38,43-46,50-51,73-74,82-93,101,103-119,131-135,174,206-211H,17,26-32,39-42,47-49,52-72,75-81,164-166H2,1-16H3,(H2,167,227)(H,170,178)(H,171,216)(H,172,212)(H,175,233)(H,176,235)(H,177,234)(H,179,228)(H,180,232)(H,181,236)(H,182,251)(H,183,213)(H,184,214)(H,185,229)(H,186,230)(H,187,239)(H,188,237)(H,189,249)(H,190,231)(H,191,240)(H,192,241)(H,193,238)(H,194,246)(H,195,247)(H,196,252)(H,197,248)(H,198,250)(H,199,253)(H,200,215)(H,201,242)(H,202,245)(H,203,243)(H,204,244)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H4,168,169,173)/t87-,88-,89-,90-,91-,92+,93+,101-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,131-,132-,133-,134-,135-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 37n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152767
PNG
(CHEMBL410973 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C162H242N42O51/c1-17-85(10)132(159(251)181-89(14)139(231)189-113(68-95-71-173-100-36-25-24-35-98(95)100)149(241)191-109(64-82(4)5)150(242)200-130(83(6)7)157(249)188-102(37-26-28-55-163)141(233)174-73-120(213)182-101(135(166)227)39-30-57-172-162(167)168)202-151(243)111(65-92-31-20-18-21-32-92)192-146(238)107(47-53-128(223)224)187-145(237)103(38-27-29-56-170-123(216)79-255-62-61-254-60-58-171-119(212)54-59-204-124(217)49-50-125(204)218)184-137(229)87(12)178-136(228)86(11)180-144(236)106(44-48-118(165)211)183-121(214)74-175-143(235)105(46-52-127(221)222)186-147(239)108(63-81(2)3)190-148(240)110(67-94-40-42-97(210)43-41-94)193-154(246)115(76-205)196-156(248)117(78-207)197-158(250)131(84(8)9)201-153(245)114(70-129(225)226)194-155(247)116(77-206)198-161(253)134(91(16)209)203-152(244)112(66-93-33-22-19-23-34-93)195-160(252)133(90(15)208)199-122(215)75-176-142(234)104(45-51-126(219)220)185-138(230)88(13)179-140(232)99(164)69-96-72-169-80-177-96/h18-25,31-36,40-43,49-50,71-72,80-91,99,101-117,130-134,173,205-210H,17,26-30,37-39,44-48,51-70,73-79,163-164H2,1-16H3,(H2,165,211)(H2,166,227)(H,169,177)(H,170,216)(H,171,212)(H,174,233)(H,175,235)(H,176,234)(H,178,228)(H,179,232)(H,180,236)(H,181,251)(H,182,213)(H,183,214)(H,184,229)(H,185,230)(H,186,239)(H,187,237)(H,188,249)(H,189,231)(H,190,240)(H,191,241)(H,192,238)(H,193,246)(H,194,247)(H,195,252)(H,196,248)(H,197,250)(H,198,253)(H,199,215)(H,200,242)(H,201,245)(H,202,243)(H,203,244)(H,219,220)(H,221,222)(H,223,224)(H,225,226)(H4,167,168,172)/t85-,86-,87-,88-,89-,90+,91+,99-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,130-,131-,132-,133-,134-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 72n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor (GLP-1)


(Homo sapiens (Human))
BDBM50152773
PNG
(CHEMBL412288 | GLP-17-(7-36) derivative)
Show InChI InChI=1S/C161H240N42O51/c1-17-84(10)131(158(250)180-88(14)138(230)188-112(67-94-70-172-99-35-25-24-34-97(94)99)148(240)190-108(63-81(4)5)149(241)199-129(82(6)7)156(248)187-101(140(232)173-72-119(212)181-100(134(165)226)37-28-56-171-161(166)167)38-29-55-169-122(215)78-254-61-60-253-59-57-170-118(211)53-58-203-123(216)48-49-124(203)217)201-150(242)110(64-91-30-20-18-21-31-91)191-145(237)106(46-52-127(222)223)186-144(236)102(36-26-27-54-162)183-136(228)86(12)177-135(227)85(11)179-143(235)105(43-47-117(164)210)182-120(213)73-174-142(234)104(45-51-126(220)221)185-146(238)107(62-80(2)3)189-147(239)109(66-93-39-41-96(209)42-40-93)192-153(245)114(75-204)195-155(247)116(77-206)196-157(249)130(83(8)9)200-152(244)113(69-128(224)225)193-154(246)115(76-205)197-160(252)133(90(16)208)202-151(243)111(65-92-32-22-19-23-33-92)194-159(251)132(89(15)207)198-121(214)74-175-141(233)103(44-50-125(218)219)184-137(229)87(13)178-139(231)98(163)68-95-71-168-79-176-95/h18-25,30-35,39-42,48-49,70-71,79-90,98,100-116,129-133,172,204-209H,17,26-29,36-38,43-47,50-69,72-78,162-163H2,1-16H3,(H2,164,210)(H2,165,226)(H,168,176)(H,169,215)(H,170,211)(H,173,232)(H,174,234)(H,175,233)(H,177,227)(H,178,231)(H,179,235)(H,180,250)(H,181,212)(H,182,213)(H,183,228)(H,184,229)(H,185,238)(H,186,236)(H,187,248)(H,188,230)(H,189,239)(H,190,240)(H,191,237)(H,192,245)(H,193,246)(H,194,251)(H,195,247)(H,196,249)(H,197,252)(H,198,214)(H,199,241)(H,200,244)(H,201,242)(H,202,243)(H,218,219)(H,220,221)(H,222,223)(H,224,225)(H4,166,167,171)/t84-,85-,86-,87-,88-,89+,90+,98-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,129-,130-,131-,132-,133-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 49n/an/an/an/a



ConjuChem Inc.

Curated by ChEMBL


Assay Description
Effective concentration against human GLP1 receptor expressed in CHO cells


Bioorg Med Chem Lett 14: 4395-8 (2004)


Article DOI: 10.1016/j.bmcl.2004.06.066
BindingDB Entry DOI: 10.7270/Q25X28FC
More data for this
Ligand-Target Pair